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Quantifying malaria risk in travellers: a quixotic pursuit
Elizabeth A. Davlantes, MD*, Kathrine R. Tan, MD, and Paul M. Arguin, MD
Centers for Disease Control and Prevention, Center for Global Health, Division of Parasitic 
Diseases and Malaria, Malaria Branch, Atlanta, Georgia, USA
Every year, millions of travellers visit countries in which malaria is endemic. To help inform 
prevention guidelines, there have been many attempts to quantify malaria risk in travellers. 
Unfortunately, the data needed to accurately calculate such risk do not exist. Current 
methods and datasets can provide approximations, but as we will explain, they greatly 
underestimate the true risk value. Presenting such underestimates as precise measurements 
and using them as the basis for policy decisions has the potential to cause real harm or death 
to travellers from a disease easily preventable by chemoprophylaxis. Instead, a more holistic 
approach to determining malaria risk is needed to best protect travellers. Such an approach 
could include a qualitative assessment of surveillance data and individual characteristics of 
the traveller.
It is common to use attack rates to estimate risk. However, in the travel medicine literature, 
the methods used to calculate malaria attack rates to approximate individual risk1–3 are 
flawed. For example, authors often determine the number of cases of imported malaria from 
an endemic area to non-endemic countries reported in national surveillance systems, divide 
by the estimated total number of travellers from non-endemic countries to this region, and 
use the resulting quotient to make recommendations on chemoprophylaxis for travellers. 
Such a calculation has limitations that have been acknowledged in passing, but as we will 
describe, these limitations are actually quite major and if overlooked can result in very 
dangerous and erroneous conclusions.
A basic epidemiologic tenet is that for rates and risks, the numerator and denominator 
should be derived from the same at-risk population. When looking at all travellers to a 
specific malaria-endemic country, there are potentially three risk groups—those who visited 
non-endemic areas (Figure 1A), those who visited endemic areas while taking antimalarials 
for prophylaxis, and those who visited endemic areas without taking chemoprophylaxis 
(Figure 1B). Those who travelled to a non-endemic area are not at risk for malaria, and 
therefore should not be in the numerator or denominator.
The total number of malaria cases among travellers includes malaria diagnosed during 
travel, malaria diagnosed after travel, undiagnosed malaria that was self-treated, and malaria 
causing death abroad. In addition, if travellers on chemoprophylaxis are included in the 
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denominator, the corresponding numerator must include those who were bitten by an 
infective mosquito but were protected from developing disease by malaria prophylaxis 
(malaria averted) (Figure 1C). If the rate of malaria in only unprotected individuals is 
desired, then the numerator should not include cases averted, and the denominator should 
not include those who were on prophylaxis. (Figure 1D).
The data used to derive numerators and denominators for malaria rate calculations are also 
problematic. Data sources used to quantify the total number of travellers to specific 
countries, such as airport surveys or data from national or international tourism databases4 
usually do not discriminate between travellers to non-endemic versus endemic parts of the 
destination country or between travellers who take prophylaxis and those who do not. 
Different countries also use different methods for estimating travel volume, including 
individual passenger arrivals at ports of entry or overnights stays at hotels by persons 
holding a foreign passport, making comparisons across countries less reliable. Numerators 
are often derived from national surveillance data in travellers’ home countries,5 but cases 
can be underreported there. Travellers who died, were diagnosed during travel, or who 
empirically self-treated are frequently not captured by their home country surveillance 
systems, nor are malaria cases averted by prevention measures. National surveillance data 
may also be unable to pinpoint the location of parasite acquisition, particularly for travellers 
to countries with geographically varied malaria transmission, trips spanning multiple 
countries, or those with imprecise travel histories. Furthermore, time spent during travel in a 
malaria-endemic area, an essential element for calculating rates or risk, is usually not 
available from surveillance data.
Pairing a falsely small numerator (missing cases of malaria self-treated, diagnosed or died 
abroad, or averted) with a falsely large denominator (including travellers visiting malaria-
free regions or taking chemoprophylaxis) will inevitably underestimate the true malaria risk, 
potentially by several orders of magnitude (Figure 1E). Malaria prophylaxis 
recommendations and policies based on such underestimations, particularly when presented 
as precise calculations, can put travellers at increased risk for malaria. This is akin to 
stopping an effective vaccination program when coverage rates are high because incident 
cases appear to be declining.
As health practitioners and scientists, we must value data-driven policies and practice 
evidence-based medicine. It is therefore incumbent upon the travel medicine community to 
use appropriate methods and to make recommendations that truly reflect the uncertain 
quality and limited availability of the evidence. Given that the optimal data to calculate 
meaningful malaria rates and risk do not exist and are unlikely to be available, attempts to 
quantify malaria risk should be put aside.
A more holistic approach is instead needed. Keeping in mind the described limitations, 
numbers of cases in surveillance systems and travel volume data can be used to qualitatively 
inform the guideline process, particularly when considered in the context of additional 
information such as sub-national endemic country surveillance data. Examples and further 
details of such qualitative assessment can be found in the United States Centers for Disease 
Control and Prevention’s Yellow Book.6 Then, when deciding on malaria prevention 
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recommendations for an individual traveller, travel medicine professionals should take into 
account both local malaria rates and patient details, such as type of travel or past medical 
history. To protect travellers as well as possible, it is essential that we follow basic 
epidemiologic principles so as to have an accurate understanding of where and when malaria 
transmission occurs. This knowledge will help to ensure travellers receive the best possible 
recommendations for malaria prophylaxis.
Acknowledgments
Funding
This work has not been presented at any meetings. This work was supported by the United States Centers for 
Disease Control and Prevention. We are employees of this agency and have no grants or other financial support to 
declare.
References
1. Askling H, Nilsson J, Tegnell A, Janzon R, Ekdahl K. Malaria risk in travelers. Emerg Infect Dis. 
2005; 11:436–41. [PubMed: 15757560] 
2. Behrens R, Carroll B, Hellgren U, et al. The incidence of malaria in travellers to South-East Asia: is 
local malaria transmission a useful risk indicator? Malar J. 2010; 9:266. [PubMed: 20920352] 
3. Freedman D, Chen LH, Kozarsky PE. Medical considerations before international travel. N Egl J 
Med. 2016; 375:247–60.
4. Spencer B, Steele W, Custer B, et al. Risk for malaria in United States donors deferred for travel to 
malaria-endemic areas. Transfusion. 2009; 49:2335–45. [PubMed: 19903290] 
5. Arhem K, Gysin N, Nielsen HV, Surya A, Hellgren U. Low and declining risk for malaria in visitors 
to Indonesia: a review of local Indonesian and European travelers’ data and a suggestion for new 
prophylactic guidelines. J Travel Med. 2015; 22:398–5.
6. United States Centers for Disease Control and Prevention. CDC Health Information for International 
Travel 2018. New York, NY: Oxford University Press; 2017. p. 373-4.
Davlantes et al. Page 3
J Travel Med. Author manuscript; available in PMC 2018 January 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Calculation of attack rates for travelers to malaria endemic areas
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